CureC9, a patient-driven initiative dedicated to accelerating treatments for C9orf72-associated amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD), has partnered with BrainXell, Inc. to expand
Understanding myelination requires more than studying oligodendrocytes alone. It requires human relevant models that capture the complex interactions between neurons, glial cells, and the surrounding
As neuroscience research continues to seek more predictive and human-relevant model systems, BrainXell is expanding beyond individual cell types to develop integrated platforms that better
BrainXell announced the launch of its human induced pluripotent stem cell (iPSC)-derived sensory neurons, a scalable human cellular platform engineered to support reproducible functional studies
